Covered recipient · General Payments record
LAURA SAHYOUN
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2022–2024
$2,018.31
- Reported across 39 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,196.42 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $628.49 | 15 |
| Lilly USA, LLC | $131.69 | 2 |
| Janssen Biotech, Inc. | $117.39 | 1 |
| Celgene Corporation | $115.31 | 4 |
| Janssen Scientific Affairs, LLC | $108.04 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $48.79 | 3 |
| Celltrion USA Inc. | $46.71 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $27.39 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106000877 | CMS |
| ABBVIE INC. | $139.93 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106000879 | CMS |
| ABBVIE INC. | $17.35 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106000881 | CMS |
| ABBVIE INC. | $32.55 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106000883 | CMS |
| ABBVIE INC. | $17.86 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106000885 | CMS |
| ABBVIE INC. | $0.33 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106000887 | CMS |
| ABBVIE INC. | $33.76 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106000889 | CMS |
| ABBVIE INC. | $168.76 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106000891 | CMS |
| ABBVIE INC. | $37.07 | 05/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106000893 | CMS |
| ABBVIE INC. | $34.83 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106000895 | CMS |
| ABBVIE INC. | $14.12 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106000897 | CMS |
| ABBVIE INC. | $34.46 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106000899 | CMS |
| ABBVIE INC. | $25.28 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106000901 | CMS |
| ABBVIE INC. | $14.96 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106000903 | CMS |
| ABBVIE INC. | $29.84 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106000905 | CMS |
| Celgene Corporation | $32.48 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101130520 | CMS |
| Celgene Corporation | $16.39 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101130524 | CMS |
| Celgene Corporation | $33.22 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101130532 | CMS |
| Celgene Corporation | $33.22 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101130534 | CMS |
| Celltrion USA Inc. | $46.71 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1075857559 | CMS |
| Janssen Biotech, Inc. | $117.39 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078446341 | CMS |
| Janssen Scientific Affairs, LLC | $108.04 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078856122 | CMS |
| Lilly USA, LLC | $6.69 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135133290 | CMS |
| Lilly USA, LLC | $125.00 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135133292 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.60 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137666758 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.49 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137666760 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.70 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137666762 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.